Coagulation status and biochemical and inflammatory markers in multiple sclerosis

被引:45
作者
Aksungar, Fehime B. [1 ]
Topkaya, Aynur E. [2 ]
Yildiz, Zeynep [3 ]
Sahin, Sevkl [4 ]
Turk, Ulku [3 ]
机构
[1] Maltepe Univ, Sch Med, Dept Biochem, TR-34844 Istanbul, Turkey
[2] Maltepe Univ, Sch Med, Dept Microbiol, TR-34844 Istanbul, Turkey
[3] Kartal Lufti Kirdar Educ & Training Hosp, Dept Neurol, Istanbul, Turkey
[4] Maltepe Univ, Sch Med, Dept Neurol, TR-34844 Istanbul, Turkey
关键词
MS; coagulation; D-dimer; homocysteine; CRP; fibrinogen;
D O I
10.1016/j.jocn.2007.02.090
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system and is the most common cause of neurologic disability in young adults. in this study, the coagulation status and biochemical and non-specific inflammatory markers in patients with MS were investigated. Plasma prothrombin time, activated partial thrombin time, fibrinogen, D-dimer, serum high sensitive C-reactive protein, homocysteine, blood urea nitrogen, creatinine, calcium, total protein, albumin, total cholesterol, vitamin B 12, folate levels and erythrocyte sedimentation rate were measured in 42 patients with MS and 31 healthy subjects as a control group. There was a positive correlation between homocysteine and D-dimer levels (r = 0.84, p < 0.01). However, there was no significant correlation between homocysteine, vitamin B12 (r = 0.18) and folate (r = 0.23) levels. Serum total protein, albumin and calcium levels of MS patients were lower than the control group. There are some alterations in the coagulation and biochemical status in MS patients. These findings may contribute to better understanding of the etiopathogenesis and clinical characteristics of this disease. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:393 / 397
页数:5
相关论文
共 31 条
[1]   Nervous system pathology: The fibrin perspective [J].
Akassoglou, K ;
Strickland, S .
BIOLOGICAL CHEMISTRY, 2002, 383 (01) :37-45
[2]  
Baig SM, 1995, BIOGENIC AMINES, V11, P479
[3]   Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory [J].
Calabresi, P ;
Napolitano, M ;
Centonze, D ;
Marfia, GA ;
Gubellini, P ;
Teule, MA ;
Berretta, N ;
Bernardi, G ;
Frati, L ;
Tolu, M ;
Gulino, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (03) :1002-1012
[4]  
Chandler WL, 2000, HAEMOSTASIS, V30, P204
[5]  
CHARCOT J, 1868, COMPTES RENDUS CENCE
[6]  
Charcot JM, 1868, GAZ HOP PARIS, V41, P554
[7]   Apolipoprotein Eε4 is associated with rapid progression of multiple sclerosis [J].
Fazekas, F ;
Strasser-Fuchs, S ;
Kollegger, H ;
Berger, T ;
Kristoferitsch, W ;
Schmidt, H ;
Enzinger, C ;
Schiefermeier, M ;
Schwarz, C ;
Kornek, B ;
Reindl, M ;
Huber, K ;
Grass, R ;
Wimmer, G ;
Vass, K ;
Pfeiffer, KH ;
Hartung, HP ;
Schmidt, R .
NEUROLOGY, 2001, 57 (05) :853-857
[8]   Soluble E-selectin in multiple sclerosis: Raised concentrations in patients with primary progressive disease [J].
Giovannoni, G ;
Thorpe, JW ;
Kidd, D ;
Kendall, BE ;
Moseley, IF ;
Thompson, AJ ;
Keir, G ;
Miller, DH ;
Feldmann, M ;
Thompson, EJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (01) :20-26
[9]   Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors [J].
Gveric, D ;
Herrera, B ;
Petzold, A ;
Lawrence, DA ;
Cuzner, ML .
BRAIN, 2003, 126 :1590-1598
[10]   Multiple sclerosis [J].
Hafler, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (06) :788-794